European Archives - Page 763 of 996 - European Medical Journal

Introducing EMJ Cardiology 5.1

United Kingdom, October 12, 2017: European Medical Journal would like to welcome you to the latest edition of EMJ Cardiology.

MC2 Therapeutics A/S Announces First Patient Dosed in Pivotal US Phase 3 Trial in Psoriasis Vulgaris

Copenhagen, Denmark, 11 October, 2017 – MC2 Therapeutics A/S, a clinical-stage dermatology and eye care company today announced that first patient…

Differences in The Expression of Lectin-like Oxidised Low-Density Lipoprotein Receptor-1 in Human Epicardial and Intramyocardial Coronary Arteries

The difference in atherogenic properties of intramyocardial coronary arteries (ICA) and epicardial coronary arteries (ECA)…

EMJ Cardiology 5.1 2017

European Medical Journal would like to welcome you to the latest edition of EMJ Cardiology. Packed with the latest research findings and opinions…

Review of the European Society of Cardiology Congress 2017

The glorious city of Barcelona, Spain was resplendent in the summer sun this August, as cardiologists from all over the world flocked to take part in the…

More than 1,500 Procedures Experience in no X-Ray Catheter Ablation Of Supraventricular Arrhythmias

Catheter ablation (CA) with the use of fluoroscopy became a gold standard of treatment for recurring regular supraventricular tachycardias…

Editor’s Pick: Protecting the Heart in Cancer Patients: The Role of Cardio-Oncology

Cardiac disease often impacts cancer therapy, from direct toxicity of cancer therapeutic agents to the coronary endothelium, the myocardium, heart valves…

Bioresorbable Coronary Scaffolds: Current State of Evidence

Second-generation drug-eluting stents are currently considered the standard of care in patients undergoing treatment for coronary artery disease…

Previous Catheter Ablation: The Strongest Predictor of Conversion in Acute Atrial Fibrillation

The prevalence of atrial fibrillation (AF) increases every year; some scientists project that between 2010 and 2060 the number of…

Pathophysiology of Ischaemic Mitral Valve Prolapse: A Review of the Evidence and Implications for Surgical Treatment

Ischaemic mitral prolapse (IMP) is a pathologic entity encountered in about one-third of patients undergoing surgery for ischaemic mitral regurgitation.